Metformin use in chronic kidney disease: new evidence to guide dosing.

Metformin use in chronic kidney disease: new evidence to guide dosing.

Bibliographic Details
Main Authors:	Herrington, W, Nye, H, Aung, T
Format:	Journal article
Language:	English
Published:	2013

Similar Items

Metformin: the safest hypoglycaemic agent in chronic kidney disease?
by: Nye, H, et al.
Published: (2011)

Conventional and genetic evidence on the association between adiposity and chronic kidney disease
by: Zhu, P, et al.
Published: (2020)

Empagliflozin and cardiovascular outcomes in patients with chronic kidney disease: the EMPA-KIDNEY trial
by: Preiss, D, et al.
Published: (2022)

Retarding Progression of Chronic Kidney Disease in Autosomal Dominant Polycystic Kidney Disease with Metformin and Other Therapies: An Update of New Insights
by: Carullo N, et al.
Published: (2021-09-01)

Metformin doses to ensure efficacy and safety in patients with reduced kidney function.
by: Isabelle H S Kuan, et al.
Published: (2021-01-01)

Significance of Metformin Use in Diabetic Kidney Disease
by: Daiji Kawanami, et al.
Published: (2020-06-01)

Antibiotic Dosing in Chronic Kidney Disease
by: N. D. Bunyatyan, et al.
Published: (2021-12-01)

Metformin improves diabetic kidney disease
by: Beladi Mousavi Seyed Seifollah, et al.
Published: (2012-01-01)

Limitations of metformin use in patients with kidney disease: are they warranted?
Published: (2010-12-01)

The Effect of Metformin in Diabetic and Non-Diabetic Rats with Experimentally-Induced Chronic Kidney Disease
by: Mohammed Al Za’abi, et al.
Published: (2021-05-01)

Metformin prevents stroke damage in non-diabetic female mice with chronic kidney disease
by: Maria Grissi, et al.
Published: (2021-04-01)

Metformin use and cardiovascular outcomes in patients with diabetes and chronic kidney disease: a nationwide cohort study
by: Min-Ho Kim, et al.
Published: (2021-12-01)

Chronic kidney disease, heart failure and neprilysin inhibition
by: Haynes, R, et al.
Published: (2019)

Administration of metformin in type 2 diabetes mellitus patients with chronic kidney disease; facts and myths
by: Mohsen Akhavan Sepahi, et al.
Published: (2020-01-01)

Dose adjustment of antidiabetic medications in chronic kidney disease
by: Matthew Salvatore Snyder, et al.
Published: (2021-01-01)

Rational dosing of gabapentin and pregabalin in chronic kidney disease
by: Raouf M, et al.
Published: (2017-01-01)

Design considerations for future renoprotection trials in the era of multiple therapies for chronic kidney disease
by: Zhu, D, et al.
Published: (2024)

Daily dose of metformin caused acute kidney injury with lactic acidosis: a case report
by: Maho Ariga, et al.
Published: (2023-09-01)

Repurposing of metformin and colchicine reveals differential modulation of acute and chronic kidney injury
by: Maryam El-Rashid, et al.
Published: (2020-12-01)

Drug-Dosing Adjustment in Dogs and Cats with Chronic Kidney Disease
by: Francesca De Santis, et al.
Published: (2022-01-01)

Evidence for reverse causality in the association between blood pressure and cardiovascular risk in patients with chronic kidney disease
by: Herrington, W, et al.
Published: (2016)

Metformin Protects against Podocyte Injury in Diabetic Kidney Disease
by: Sanna Lehtonen
Published: (2020-12-01)

Appropriateness of metformin prescription for type 2 diabetes mellitus patients with chronic kidney disease (Stages 3-5)
by: Ramachandran, Mohana, et al.
Published: (2020)

ERBP guideline on management of patients with diabetes and chronic kidney disease stage 3B or higher. Metformin for all?
by: Alberto Martínez-Castelao, et al.
Published: (2017-11-01)

Metformin attenuates chronic lung allograft dysfunction: evidence in rat models
by: Dong Tian, et al.
Published: (2023-07-01)

Low-dose aspirin for prevention of cardiovascular disease in patients with chronic kidney disease.
by: Ae Jin Kim, et al.
Published: (2014-01-01)

Metformin Use and Risk of All-Cause Mortality and Cardiovascular Events in Patients With Chronic Kidney Disease—A Systematic Review and Meta-Analysis
by: Yao Hu, et al.
Published: (2020-10-01)

Efficacy of low dose spironolactone in chronic kidney disease with resistant hypertension
by: Rozita Abolghasmi, et al.
Published: (2011-01-01)

Chronic kidney disease: a practical guide (ACT-NAU)
by: Ana Corte-Real, et al.
Published: (2024-02-01)

Gallic acid improves the metformin effects on diabetic kidney disease in mice
by: Yan Hong, et al.
Published: (2023-12-01)

New loci associated with kidney function and chronic kidney disease.
by: Köttgen, A, et al.
Published: (2010)

A policy model of cardiovascular disease in moderate-to-advanced chronic kidney disease
by: Schlackow, I, et al.
Published: (2017)

Effects of Metformin on Ischemia/Reperfusion Injury: New Evidence and Mechanisms
by: Estefanie Osorio-Llanes, et al.
Published: (2023-08-01)

Cost-effectiveness of lowering LDL cholesterol with statins and ezetimibe in chronic kidney disease
by: Mihaylova, B, et al.
Published: (2019)

Metformin treatment for patients with diabetes and chronic kidney disease: A Korean Diabetes Association and Korean Society of Nephrology consensus statement
by: Kyu Yeon Hur, et al.
Published: (2020-03-01)

Metformin Treatment for Patients with Diabetes and Chronic Kidney Disease: A Korean Diabetes Association and Korean Society of Nephrology Consensus Statement
by: Kyu Yeon Hur, et al.
Published: (2020-02-01)

Insight into the Molecular Mechanism of Diabetic Kidney Disease and the Role of Metformin in Its Pathogenesis
by: Marcin Kleibert, et al.
Published: (2023-08-01)

Metformin and Canagliflozin Are Equally Renoprotective in Diabetic Kidney Disease but Have No Synergistic Effect
by: Raphaëlle Corremans, et al.
Published: (2023-05-01)

Lactate levels and risk of lactic acidosis with metformin in diabetic kidney disease patients
by: P K Bipi, et al.
Published: (2017-01-01)

Metformin in autosomal dominant polycystic kidney disease: experimental hypothesis or clinical fact?
by: Antonio Pisani, et al.
Published: (2018-10-01)